Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

3(42.9%)

N/A

3(42.9%)

Phase 4

1(14.3%)

7Total

Phase 2(3)

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07518875Not ApplicableEnrolling By Invitation

Online Dietary Weight Loss Program for Arab Adults: A Randomized Controlled Trial

Role: collaborator

NCT07193849Phase 4Recruiting

Zinc Oxide VS MEBO

Role: lead

NCT06790277Not ApplicableRecruiting

Polyurethane Foam-Pink Pad (RCT) Use in OR

Role: lead

NCT06415695Not ApplicableCompleted

Evaluating the Feasibility of a Dietary Weight Loss Program to Overcome Obesity and Its Comorbidity Among Arab Populations

Role: collaborator

NCT03957733Phase 2Unknown

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

Role: lead

NCT04099693Unknown

A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP

Role: lead

NCT03940131Phase 2Unknown

Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR

Role: lead

NCT02868827Phase 2Terminated

Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.

Role: lead

All 8 trials loaded